NK Cell Subset Redistribution during the Course of Viral Infections.

PubWeight™: 0.86‹?›

🔗 View Article (PMC 4132273)

Published in Front Immunol on August 14, 2014

Authors

Enrico Lugli1, Emanuela Marcenaro2, Domenico Mavilio3

Author Affiliations

1: Unit of Clinical and Experimental Immunology, Humanitas Clinical and Research Center , Milan , Italy.
2: Dipartimento di Medicina Sperimentale, Centro di Eccellenza per le Ricerche Biomediche, Università degli Studi di Genova , Genova , Italy.
3: Unit of Clinical and Experimental Immunology, Humanitas Clinical and Research Center , Milan , Italy ; Dipartimento di Medicina Sperimentale, Centro di Eccellenza per le Ricerche Biomediche, Università degli Studi di Genova , Genova , Italy ; Department of Medical Biotechnologies and Translational Medicine, University of Milan , Milan , Italy.

Articles cited by this

NK cell recognition. Annu Rev Immunol (2005) 14.40

The biology of human natural killer-cell subsets. Trends Immunol (2001) 10.10

Functions of natural killer cells. Nat Immunol (2008) 9.88

Innate or adaptive immunity? The example of natural killer cells. Science (2011) 8.68

Adaptive immune features of natural killer cells. Nature (2009) 8.46

Severe herpesvirus infections in an adolescent without natural killer cells. N Engl J Med (1989) 7.52

Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis. Annu Rev Immunol (2001) 7.07

Densely interconnected transcriptional circuits control cell states in human hematopoiesis. Cell (2011) 7.03

Costimulation of CD8alphabeta T cells by NKG2D via engagement by MIC induced on virus-infected cells. Nat Immunol (2001) 5.48

ULBPs, novel MHC class I-related molecules, bind to CMV glycoprotein UL16 and stimulate NK cytotoxicity through the NKG2D receptor. Immunity (2001) 5.42

Cell stress-regulated human major histocompatibility complex class I gene expressed in gastrointestinal epithelium. Proc Natl Acad Sci U S A (1996) 4.69

Receptors for HLA class-I molecules in human natural killer cells. Annu Rev Immunol (1996) 4.24

Natural killer cells, viruses and cancer. Nat Rev Immunol (2001) 4.21

Cytomegalovirus reactivation after allogeneic transplantation promotes a lasting increase in educated NKG2C+ natural killer cells with potent function. Blood (2011) 3.66

Expansion of a unique CD57⁺NKG2Chi natural killer cell subset during acute human cytomegalovirus infection. Proc Natl Acad Sci U S A (2011) 3.53

Natural killer cells and dendritic cells: rendezvous in abused tissues. Nat Rev Immunol (2002) 3.45

T cell depletion in HIV-1 infection: how CD4+ T cells go out of stock. Nat Immunol (2000) 3.33

Human natural killer cell development. Immunol Rev (2006) 3.14

Natural-killer cells and dendritic cells: "l'union fait la force". Blood (2005) 3.10

Rapid expansion and long-term persistence of elevated NK cell numbers in humans infected with hantavirus. J Exp Med (2010) 2.89

Education of human natural killer cells by activating killer cell immunoglobulin-like receptors. Blood (2009) 2.88

A fresh look at tumor immunosurveillance and immunotherapy. Nat Immunol (2001) 2.87

Characterization of CD56-/CD16+ natural killer (NK) cells: a highly dysfunctional NK subset expanded in HIV-infected viremic individuals. Proc Natl Acad Sci U S A (2005) 2.80

Close encounters of different kinds: dendritic cells and NK cells take centre stage. Nat Rev Immunol (2005) 2.77

Pathogenesis of murine cytomegalovirus infection in natural killer cell-depleted mice. J Virol (1984) 2.73

NK cell and DC interactions. Trends Immunol (2004) 2.68

NK cells in HIV infection: paradigm for protection or targets for ambush. Nat Rev Immunol (2005) 2.54

Natural killer cells in HIV-1 infection: dichotomous effects of viremia on inhibitory and activating receptors and their functional correlates. Proc Natl Acad Sci U S A (2003) 2.51

Sequential deregulation of NK cell subset distribution and function starting in acute HIV-1 infection. Blood (2005) 2.50

Human cytomegalovirus infection is associated with increased proportions of NK cells that express the CD94/NKG2C receptor in aviremic HIV-1-positive patients. J Infect Dis (2006) 2.49

Role of chemokines in the biology of natural killer cells. J Leukoc Biol (2002) 2.34

The impaired NK cell cytolytic function in viremic HIV-1 infection is associated with a reduced surface expression of natural cytotoxicity receptors (NKp46, NKp30 and NKp44). Eur J Immunol (2003) 2.29

Siglec-1 is a novel dendritic cell receptor that mediates HIV-1 trans-infection through recognition of viral membrane gangliosides. PLoS Biol (2012) 2.03

The role of chemerin in the colocalization of NK and dendritic cell subsets into inflamed tissues. Blood (2007) 1.99

Human cytomegalovirus (CMV)-induced memory-like NKG2C(+) NK cells are transplantable and expand in vivo in response to recipient CMV antigen. J Immunol (2012) 1.98

Control of human viral infections by natural killer cells. Annu Rev Immunol (2013) 1.96

Phenotypic and functional heterogeneity of human NK cells developing after umbilical cord blood transplantation: a role for human cytomegalovirus? Blood (2011) 1.78

IL-18-induced CD83+CCR7+ NK helper cells. J Exp Med (2005) 1.76

Human NK cells can control CMV infection in the absence of T cells. Blood (2008) 1.75

Revisiting human natural killer cell subset function revealed cytolytic CD56(dim)CD16+ NK cells as rapid producers of abundant IFN-gamma on activation. Proc Natl Acad Sci U S A (2010) 1.74

Characterization of the defective interaction between a subset of natural killer cells and dendritic cells in HIV-1 infection. J Exp Med (2006) 1.72

Dendritic and natural killer cells cooperate in the control/switch of innate immunity. J Exp Med (2002) 1.68

Reciprocal regulation of human natural killer cells and macrophages associated with distinct immune synapses. Blood (2007) 1.66

Serial killing of tumor cells by human natural killer cells--enhancement by therapeutic antibodies. PLoS One (2007) 1.61

Sialoadhesin expressed on IFN-induced monocytes binds HIV-1 and enhances infectivity. PLoS One (2008) 1.59

Donor KIR genotype has a major influence on the rate of cytomegalovirus reactivation following T-cell replete stem cell transplantation. Blood (2005) 1.58

Natural killer cell immunodeficiency in HIV disease is manifest by profoundly decreased numbers of CD16+CD56+ cells and expansion of a population of CD16dimCD56- cells with low lytic activity. J Acquir Immune Defic Syndr Hum Retrovirol (1995) 1.53

The small subset of CD56brightCD16- natural killer cells is selectively responsible for both cell proliferation and interferon-gamma production upon interaction with dendritic cells. Eur J Immunol (2004) 1.50

Immune reconstitution after hematopoietic cell transplantation. Curr Opin Hematol (2012) 1.48

Lysis of endogenously infected CD4+ T cell blasts by rIL-2 activated autologous natural killer cells from HIV-infected viremic individuals. PLoS Pathog (2008) 1.44

Selective depletion of CD56(dim) NK cell subsets and maintenance of CD56(bright) NK cells in treatment-naive HIV-1-seropositive individuals. J Clin Immunol (2002) 1.33

CD56negCD16⁺ NK cells are activated mature NK cells with impaired effector function during HIV-1 infection. Retrovirology (2013) 1.30

CD56 negative NK cells: origin, function, and role in chronic viral disease. Trends Immunol (2010) 1.30

The interaction of human natural killer cells with either unpolarized or polarized macrophages results in different functional outcomes. Proc Natl Acad Sci U S A (2010) 1.28

Chronic HIV-1 viremia reverses NKG2A/NKG2C ratio on natural killer cells in patients with human cytomegalovirus co-infection. AIDS (2010) 1.27

Expansion of functionally skewed CD56-negative NK cells in chronic hepatitis C virus infection: correlation with outcome of pegylated IFN-alpha and ribavirin treatment. J Immunol (2009) 1.24

CMV and Immunosenescence: from basics to clinics. Immun Ageing (2012) 1.17

The decreased expression of Siglec-7 represents an early marker of dysfunctional natural killer-cell subsets associated with high levels of HIV-1 viremia. Blood (2009) 1.15

Cord blood CD16+56- cells with low lytic activity are possible precursors of mature natural killer cells. Cell Immunol (1997) 1.14

Human cytomegalovirus infection promotes rapid maturation of NK cells expressing activating killer Ig-like receptor in patients transplanted with NKG2C-/- umbilical cord blood. J Immunol (2014) 1.12

Siglecs facilitate HIV-1 infection of macrophages through adhesion with viral sialic acids. PLoS One (2011) 1.10

Diverse immune evasion strategies by human cytomegalovirus. Immunol Res (2012) 1.08

Antiviral NK cell responses in HIV infection: II. viral strategies for evasion and lessons for immunotherapy and vaccination. J Leukoc Biol (2008) 1.06

Human neutrophils interact with both 6-sulfo LacNAc+ DC and NK cells to amplify NK-derived IFN{gamma}: role of CD18, ICAM-1, and ICAM-3. Blood (2010) 1.05

Immune evasion and recognition of the syphilis spirochete in blood and skin of secondary syphilis patients: two immunologically distinct compartments. PLoS Negl Trop Dis (2012) 1.05

Uptake of CCR7 and acquisition of migratory properties by human KIR+ NK cells interacting with monocyte-derived DC or EBV cell lines: regulation by KIR/HLA-class I interaction. Blood (2009) 1.05

Expansion of CD56- NK cells in chronic HCV/HIV-1 co-infection: reversion by antiviral treatment with pegylated IFNalpha and ribavirin. Clin Immunol (2008) 1.04

Pathologic natural killer cell subset redistribution in HIV-1 infection: new insights in pathophysiology and clinical outcomes. J Leukoc Biol (2010) 1.03

Cytomegalovirus diseases after hematopoietic stem cell transplantation: a mini-review. Cancer Lett (2013) 0.99

Human NK Cells induce neutrophil apoptosis via an NKp46- and Fas-dependent mechanism. J Immunol (2012) 0.97

Consequences of the crosstalk between monocytes/macrophages and natural killer cells. Front Immunol (2013) 0.97

Natural killer cell distribution and trafficking in human tissues. Front Immunol (2012) 0.96

Human NK cell response to pathogens. Semin Immunol (2014) 0.96

Engagement of NKp30 on Vδ1 T cells induces the production of CCL3, CCL4, and CCL5 and suppresses HIV-1 replication. Blood (2012) 0.94

NK cells and their receptors during viral infections. Immunotherapy (2011) 0.94

Decreased NKp46 and NKG2D and elevated PD-1 are associated with altered NK-cell function in pediatric transplant patients with PTLD. Eur J Immunol (2011) 0.93

The role of natural killer cells in autoimmune liver disease: a comprehensive review. J Autoimmun (2013) 0.92

Impact of HCMV Infection on NK Cell Development and Function after HSCT. Front Immunol (2013) 0.90

Targeted lysis of HIV-infected cells by natural killer cells armed and triggered by a recombinant immunoglobulin fusion protein: implications for immunotherapy. Virology (2005) 0.90

NK-DC interaction: on the usefulness of auto-aggression. Autoimmun Rev (2005) 0.89

Dysfunctional natural killer cells, in vivo, are governed by HIV viremia regardless of whether the infected individual is on antiretroviral therapy. AIDS (2007) 0.89

NK/DC crosstalk in anti-viral response. Adv Exp Med Biol (2012) 0.88

KIR2DS1-dependent acquisition of CCR7 and migratory properties by human NK cells interacting with allogeneic HLA-C2+ DCs or T-cell blasts. Blood (2013) 0.86

Versatile signaling through NKG2D. Nat Immunol (2002) 0.85

Cord blood natural killer cells are functionally and phenotypically immature but readily respond to interleukin-2 and interleukin-12. J Interferon Cytokine Res (1995) 0.85

Functional and phenotypic assessment of neonatal human leucocytes expressing natural killer cell-associated antigens. Immunol Cell Biol (1993) 0.85

Persistence of CD16+/CD56-/2B4+ natural killer cells: a highly dysfunctional NK subset expanded in ocular myasthenia gravis. J Neuroimmunol (2006) 0.82

Healthy Neonates Possess a CD56-Negative NK Cell Population with Reduced Anti-Viral Activity. PLoS One (2013) 0.81

Different combinations of cytokines and activating receptor stimuli are required for human natural killer cell functional diversity. Cytokine (2013) 0.81

Dermatomyositis associated with lymphoproliferative disorder of NK cells and occult small cell lung carcinoma. Clin Rheumatol (2004) 0.80

CMV induces rapid NK cell maturation in HSCT recipients. Immunol Lett (2013) 0.79

Sialic acid-binding Ig-like lectin-7 interacts with HIV-1 gp120 and facilitates infection of CD4pos T cells and macrophages. Retrovirology (2013) 0.78

Articles by these authors

TLR/NCR/KIR: Which One to Use and When? Front Immunol (2014) 1.03